Press Release

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

Certara partners with NVIDIA, adding BioNeMo Agent Toolkit to its AI platform to speed up…

CertaraJuly 7, 2026

Publication

Pharmacokinetics of Fentanyl and Norfentanyl in a Rat Model of Fixed-Volume Hemorrhagic Shock

Learn how a fixed-volume rat shock model shows increased fentanyl exposure and impaired clearance, analyzed…

CertaraJuly 4, 2026

White Paper

Certara Compound Registration Performance: Scalability and Speed Across Enterprise Deployments

See how Certara's chemical registration system scales to millions of compounds, with bulk upload speed…

CertaraJuly 1, 2026

Poster

PBPK Modeling in Lieu of Clinical Endpoint Bioequivalence Study for Generic Tazarotene Cream 0.05%

Learn how Simcyp PBPK modeling established bioequivalence and supported FDA approval of a generic product

CertaraJuly 1, 2026

On-Demand Webinar

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…

CertaraJuly 1, 2026

Guide

5 Key Principles of Modern PK/PD in 2026

Explore other Phoenix solutions to enhance your PK/PD workflow and discover how Phoenix helps you…

CertaraJune 30, 2026

Guide

Hidden data gaps in compound registration and drug discovery decisions

See how compound registration gaps create bottlenecks across the DMTA cycle. Download the guide to…

Jan ChristophersonJune 29, 2026

Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Alekhya Lavu, PhD, PharmDJune 26, 2026

Poster

Mechanistic Surface pH Modelling Improves PBPK Prediction of a Weakly Acidic Drug: Case Study of Bempedoic Acid

Explore how mechanistic surface pH modeling in Simcyp improves PBPK prediction of dissolution-controlled absorption for…

CertaraJune 26, 2026

Poster

Dermal PBPK Modelling of Propylparaben with a Novel Skin Metabolism Framework

Explore how a mechanistic dermal PBPK model with experimentally scaled, layer-specific skin metabolism predicts propylparaben…

CertaraJune 26, 2026

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

Pharmacokinetics of Fentanyl and Norfentanyl in a Rat Model of Fixed-Volume Hemorrhagic Shock

Certara Compound Registration Performance: Scalability and Speed Across Enterprise Deployments

PBPK Modeling in Lieu of Clinical Endpoint Bioequivalence Study for Generic Tazarotene Cream 0.05%

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

5 Key Principles of Modern PK/PD in 2026

Hidden data gaps in compound registration and drug discovery decisions

Enhancing clinical trials with real-world evidence in pregnancy research

Mechanistic Surface pH Modelling Improves PBPK Prediction of a Weakly Acidic Drug: Case Study of Bempedoic Acid

Dermal PBPK Modelling of Propylparaben with a Novel Skin Metabolism Framework

Newsletter sign up

Quick links

Solutions

Contact